NCT03346694

Brief Summary

This study will evaluate two alternative dressings compared to a standard Island dressing presently in use at Stanford Hospital to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients. Cardiovascular surgery patients who will have a sternotomy incision as a routine part of their surgery will be approached to voluntarily participate. Participants will be randomized to one of three dressing to determine which dressing has the lowest rate of sternal wound infection. The investigators will also assess the impact of alternative dressing use on hospital 30-day readmission rates related to SSI.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
660

participants targeted

Target at P75+ for not_applicable

Timeline
109mo left

Started May 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress47%
May 2018May 2035

First Submitted

Initial submission to the registry

November 15, 2017

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 17, 2017

Completed
6 months until next milestone

Study Start

First participant enrolled

May 1, 2018

Completed
12 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2030

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2035

Last Updated

October 26, 2022

Status Verified

October 1, 2022

Enrollment Period

12 years

First QC Date

November 15, 2017

Last Update Submit

October 24, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rates of surgical site infection pertaining to each dressing studied.

    evaluate alternative dressings to determine reductions in surgical site infection (SSI) rates among cardiac surgery patients

    From Post-Operative date 0 to 7th day or earlier which ever day comes first.

Secondary Outcomes (1)

  • Impact of alternative dressings on rates of Sternal wound incision infection

    30 days after participant discharge.

Study Arms (3)

Dressing 1: Standard Island Dressing

ACTIVE COMPARATOR

Standard dressing that is applied on most patients with a sternotomy wound incision immediately after cardiovascular surgery before leaving the operating room. Dressing will be removed 48 hours after surgery.

Device: Standard Island Dressing

Dressing 2: Prevena negative pressure

ACTIVE COMPARATOR

Prevena negative pressure wound suction machine dressing applied to sternotomy wound incision immediately after cardiovascular surgery. Dressing will be in use for 7 days or removed sooner if participant is discharged before end of 7 day post-operative time period.

Device: Prevena Negative Pressure wound dressing

Dressing 3: Mepilex Border Post-Op Ag

ACTIVE COMPARATOR

Mepilex Border PostOp AG dressing impregnated with silver ions. Dressing will be in use for 7 days or removed earlier if patient is discharged before end of 7 days post0operative time period.

Device: Mepilex Border Post-Op Ag

Interventions

participant randomized to control group before end of surgery to be applied on cardiovascular heart surgical sternal incision.

Also known as: Dressing 1
Dressing 1: Standard Island Dressing

participant randomized to dressing before end of surgery to be applied on cardiovascular heart surgical sternal incision.

Also known as: Dressing 2
Dressing 2: Prevena negative pressure

Participant randomized to dressing before end of surgery to be applied on cardiovascular heart surgical sternal incision

Also known as: Dressing 3
Dressing 3: Mepilex Border Post-Op Ag

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may not qualify if:

  • Patients undergoing heart transplants, Ventricular Assist Device (VAD), with postoperative courses complicated by tamponade, take-backs, and open chest incisions will also be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford Healthcare

Stanford, California, 94305, United States

RECRUITING

Related Publications (5)

  • Lwanga, S.K. & Lemeshow, S. (1991). Sample size determination in health studies: a practical manual. World Health Organization: Geneva, Switzerland.

    BACKGROUND
  • R Core Team (2016). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.

    BACKGROUND
  • Barnes S. What's new in SSI prevention? AORN J. 2015 Jun;101(6):P10-2. doi: 10.1016/s0001-2092(15)00421-4. No abstract available.

  • Ly, E. (2015). Cardiothoracic (CT) surgery data summary- all surgical site infections by quarter 2015 [PowerPoint slides]. Retrieved from personal communication.

    RESULT
  • Kles CL, Murrah CP, Smith K, Baugus-Wellmeier E, Hurry T, Morris CD. Achieving and Sustaining Zero: Preventing Surgical Site Infections After Isolated Coronary Artery Bypass With Saphenous Vein Harvest Site Through Implementation of a Staff-Driven Quality Improvement Process. Dimens Crit Care Nurs. 2015 Sep-Oct;34(5):265-72. doi: 10.1097/DCC.0000000000000131.

Related Links

Study Officials

  • Jack Boyd, M.D.

    Cardiovascular Surgeon

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jack Boyd, M.D.

CONTACT

Clarivil Cruz Gonzales, RN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participant randomly assigned to either a control or one of two intervention groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prinicipal Investigator

Study Record Dates

First Submitted

November 15, 2017

First Posted

November 17, 2017

Study Start

May 1, 2018

Primary Completion (Estimated)

May 1, 2030

Study Completion (Estimated)

May 1, 2035

Last Updated

October 26, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations